Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FormidableMD vs Kin Meds

FormidableMD
Graded #74

Level

vs
Kin Meds
Graded #75

Level

The verdict

Too close to call — both grade 72.9/100 (C).

FormidableMD and Kin Meds land on the same WeighScore, so neither clears the other on our six graded dimensions. FormidableMD sits one line higher on the board (#74 vs #75) on the underlying tiebreak, but it's a genuine coin-flip — pick on the factors and prices that matter most to you below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueKin Meds +19
55
74
Dose & formulationKin Meds +15
78
93
Clinical oversightFormidableMD +14
88
74
Labs & monitoringFormidableMD +30
83
53
FulfillmentEven
72
72
Contract termsFormidableMD +6
61
55
FormidableMD · left barKin Meds · right bar

The numbers

MetricFormidableMDKin Meds
WeighScore72.9/10072.9/100
GradeCC
Scorecard rank#74#75
Semaglutide$169/mo (1 mg dose, compounded)$149/mo (brand Wegovy)
Tirzepatide$199/mo (10 mg dose, compounded)$149/mo (brand Zepbound)
Coverage1 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualYesYes
FormidableMD

Graded #74 · C

Strengths

  • Transparent, published dose-by-dose pricing for semaglutide ($169-$269/mo) and tirzepatide ($199-$319/mo) with no membership or commitment
  • Offers both FDA-approved and compounded GLP-1s (plus oral options) from 503A pharmacies, with a real provider at every visit
  • Boutique physician-led model bundling labs, peptides, HRT/TRT and urgent care; FSA/HSA eligible

Where it loses points

  • Florida-focused telehealth — availability outside FL is not advertised, so out-of-state access is uncertain
  • Medication cost is on top of a $199 initial consultation and $99 follow-up visits (pay-per-visit, not an all-in monthly price)
  • The 503A compounding pharmacy partner is not named on the site
Kin Meds

Graded #75 · C

Strengths

  • Publicly lists $199/mo compounded semaglutide and $249/mo compounded tirzepatide
  • Brand-name options too — Wegovy injection and pill, Zepbound, Foundayo from $149/mo entry pricing
  • LegitScript verified
  • Clearly identifies itself as the intake platform and a licensed third-party pharmacy as the dispenser
  • Broad longevity menu (Sermorelin, NAD+, Glutathione) plus TRT, hair, skin, and sexual health

Where it loses points

  • Legal entity name and state of incorporation not publicly disclosed
  • The third-party pharmacy partner isn't named, and Kin Meds isn't itself a licensed pharmacy
  • Per-state availability not listed
  • $149/mo brand pricing is the insured entry tier — cash-pay patients should expect higher real costs
  • Lab work and dose-titration support not clearly described

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard